Cited by 192Seaweed-derived Bioactive CompoundsEchinoderm biology and ecologyNatural product bioactivities and synthesis

Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo

Open access
Xue, Meilan, Ge, Yinlin, Zhang, Jinyu, Wang, Qing, Hou, Lin, Liu, Yongchao, Sun, Lingling, Li, Quan·2012·PLoS ONE

Abstract

BACKGROUND: Fucoidan is a sulfated polysaccharide derived from brown algae that has been reported to perform multiple biological activities, including antitumor activity. In this study, we examined the influence of crude fucoidan on mouse breast cancer in vitro and in vivo. MATERIALS AND METHODS: In vitro, fluorescent staining, flow cytometry and Western blot were performed to analyze apoptosis and vascular endothelial growth factor (VEGF) expression of mouse breast cancer 4T1 cells. In vivo, therapy experiments were conducted on Babl/c mice bearing breast cancer. The tumor volume and weight were measured. The number of apoptotic cells and microvascular density (MVD) in tumor tissues were assessed by TUNEL and CD34 immunostaining. Immunohistochemical assays and ELISA assay were used to detect the expression of VEGF in tissues. RESULTS: In vitro studies showed that crude fucoidan significantly decreased the viable number of 4T1 cells, induced apoptosis and down-regulated the expression of VEGF. The expression of Bcl-2 was decreased, and the ratio of Bcl-2 to Bax was significantly decreased. The expression of Survivin and phosphorylated extracellular signal regulated protein kinases (ERKs) was decreased. Cytochrome C was released from mitochondria into cytosol, and the cleaved Caspase-3 protein rose after fucoidan treatment. Intraperitoneal injection of fucoidan in breast cancer models reduced the tumor volume and weight. The enhanced antitumor efficacy was associated with decreased angiogenesis and increased induction of apoptosis. CONCLUSION: These findings indicated that crude fucoidan inhibited mouse breast cancer growth in vitro and in vivo. These data suggest that fucoidan may serve as a potential therapeutic agent for breast cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0043483

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Treatment of mouse breast cancer cells with fucoidan showed enhanced antitumor activity associated with decreased angiogenesis via down-regulation of VEGF and increased induction of apoptosis.

    “Treatment of mouse breast cancer cells with fucoidan showed that the enhanced antitumor activity was associated with decreased angiogenesis via the down-regulation of vascular endothelial growth factor and increased induction of apoptosis [65].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Xue, M., Ge, Y., Zhang, J., Wang, Q., Hou, L., Liu, Y., Sun, L., & Li, Q.
Affiliations
  • Qingdao University (CN)
  • Affiliated Hospital of Qingdao University (CN)
Corresponding author
Ge, Yinlin
Venue
PLoS ONE
Published
2012-08-20
Volume
7
Issue
8
Pages
e43483
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1988249582
Cited by
192
References
35
Citations by year
2026: 6 · 2025: 13 · 2024: 8 · 2023: 13 · 2022: 15 · 2021: 15 · 2020: 13 · 2019: 22 · 2018: 14 · 2017: 19 · 2016: 14 · 2015: 18 · 2014: 15 · 2013: 7
FWCI
18.74
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Echinoderm biology and ecology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Natural product bioactivities and synthesis
Keywords
fucoidan, breast cancer, anticancer activity, apoptosis, angiogenesis, vascular endothelial growth factor, 4T1 cells, Bcl-2/Bax ratio, survivin, ERK1/2 phosphorylation, cytochrome c release, caspase-3, microvessel density, sulfated polysaccharides, brown algae, tumor growth inhibition
MeSH terms
Survivin, Animals, Antineoplastic Agents, Breast Neoplasms, Cell Line, Enzyme-Linked Immunosorbent Assay, Female, Fibroblasts, Flow Cytometry, Polysaccharides, Repressor Proteins, Blotting, Western, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Vascular Endothelial Growth Factor A, Inhibitor of Apoptosis Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review